Release Date: 21/09/09 17:25 Summary: Request for extension to voluntary suspension Price Sensitive: No Download Document 145.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%